Evidence map›Paper›PMID 22815313›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2012

Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.

Wangda Zhou, Kishore Viswanathan, Dennis Hill, Amy C Anderson, Dennis L Wright

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates.Drug metabolism and disposition: the biological fate of chemicals · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wangda ZhouDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Kishore Viswanathan
Dennis Hill
Amy C Anderson
Dennis L Wright
University of Connecticut · US

Funding

Targeting DHFR to Design Antimicrobial AgentsR01GM067542 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI ANDERSON, AMY C. · 2003 to 2012
$2.2M
Targeting Bacillus DHFR: Structural Studies and Synthesis of InhibitorsR01AI073375 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI ANDERSON, AMY C. · 2008 to 2012
$1.7M
Potent Antifolates as New Therapeutics for MRSAR42AI065143 · NIAID · PROMILIAD BIOPHARMA, INC. · PI WRIGHT, DENNIS L. · 2010 to 2011
$1.5M
Potent and selective DHFR inhibitors for treating CryptosporidiosisR41AI065143 · NIAID · PROMILIAD BIOPHARMA, INC. · PI WRIGHT, DENNIS L · 2006 to 2006
$279k
NIAID NIH HHS AI065143NIAID NIH HHS AI073375NIAID NIH HHS R01 AI073375NIAID NIH HHS R41 AI065143NIAID NIH HHS R42 AI065143NIGMS NIH HHS GM067542NIGMS NIH HHS R01 GM067542
6 · The paper itself

Abstract

Propargyl-linked antifolates that target dihydrofolate reductase are potent inhibitors of several species of pathogenic bacteria and fungi. This novel class of antifolates possesses a relatively uncommon acetylenic linker designed to span a narrow passage in the enzyme active site and join two larger functional domains. Because the use of alkyne functionality in drug molecules is limited, it was important to evaluate some key physicochemical properties of these molecules and specifically to assess the overall stability of the acetylene. Herein, we report studies on four compounds from our lead series that vary specifically in the environment of the alkyne. We show that the compounds are soluble, chemically stable in water, as well as simulated gastric and intestinal fluids with half-lives of approximately 30 min after incubation with mouse liver microsomes. Their primary in vitro route of metabolism involves oxidative transformations of pendant functionality with little direct alteration of the alkyne. Identification of several major metabolites indicated the formation of N-oxides; the rate of formation of these oxides was highly influenced by branching substitutions around the propargyl linker. On the basis of the lessons of these metabolic studies, a more advanced inhibitor was designed, synthesized, and shown to have increased (t(1/2) = 65 min) metabolic stability while maintaining potent enzyme inhibition.

Indexed as

Drug DesignAlkynesAnimalsBiotransformationDrug StabilityFolic Acid AntagonistsHalf-LifeKineticsMiceMicrosomes, LiverModels, MolecularMolecular StructureOxidation-ReductionSolubilityStructure-Activity RelationshipTetrahydrofolate DehydrogenaseAlkynesFolic Acid AntagonistsTetrahydrofolate Dehydrogenase

Identifiers

PMID22815313
PMCPMC3463820
OpenAlexW2154820827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.